Business ❯ Corporate Strategy ❯ Mergers and Acquisitions

Market Analysis

Analyst Ratings Company Performance Investor Relations Industry Competition Competitive Landscape Industry Trends Investment Opportunities Warner Bros. Discovery Competitive Advantage Competitive Positioning Strategic Partnerships Growth Forecasts Consumer Goods Risk Assessment Investor Confidence Performance Review Feneberg's Restructuring Streaming Partnerships Darden Restaurants Competitor Landscape Broadcom US-Denmark Relations Operational Performance Intel Acquisition Strategies Sales Performance Strategic Planning Analyst Opinions Food Industry Institutional Investment

Novartis’ Del‑Desiran Misses Phase III and Triggers Large Share Selloff

The result could change investor views on the value of Novartis' $12 billion Avidity acquisition by reducing confidence in its late‑stage neuromuscular bets and prompting a formal data review with regulators.

Onsemi to Buy Synaptics for $7 Billion in All‑Stock Deal

Pizza Hut to Close 250 U.S. Restaurants in First Half of 2026 Under Yum’s Restructuring

Netflix Stock Slumps as All-Cash Warner Bid and Slower 2026 Outlook Weigh on Sentiment